About this trial
Many ambulatory networks are mainly based on diagnoses made by first-line physicians not specifically trained to join the network. Here we aim to set up a surveillance network on pediatric infectious diseases with an investment in teaching with specific trainings of participating pediatricians, increasing in use of point of care tests, and automated data extraction from the computers of the pediatricians.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
pharyngitis
otitis
pneumonia
influenza
Disqualifiers
parental refusal
Trial population
Children under 16 years with infectious disease
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Evaluation of the number of infectious diseases
proportion of children under 16 years, with infectious disease
Secondary outcomes
Evaluation of the use of point of care tests
Proportion of use of point of care tests and positivity rate according to the infectious diseases
Evaluation of the antibiotic treatments
Proportion of each antibiotic treatments according to the infectious diseases
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Association Clinique Thérapeutique Infantile du val de Marne
Lead sponsor
AFPA (Association Française de Pédiatrie Ambulatoire)
Collaborator
GlaxoSmithKline
Collaborator
Sanofi
Collaborator
Pfizer
Collaborator
Merck Sharp & Dohme LLC
Collaborator